D.E. Shaw & Co’s Minerva Neurosciences NERV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-91,355
| Closed | -$76K | – | 4338 |
|
|
2022
Q1 | $76K | Sell |
91,355
-8,806
| -9% | -$7.33K | ﹤0.01% | 3797 |
|
|
2021
Q4 | $80K | Sell |
100,161
-89,895
| -47% | -$71.8K | ﹤0.01% | 3708 |
|
|
2021
Q3 | $331K | Sell |
190,056
-127,596
| -40% | -$222K | ﹤0.01% | 3020 |
|
|
2021
Q2 | $737K | Buy |
317,652
+224,509
| +241% | +$521K | ﹤0.01% | 2689 |
|
|
2021
Q1 | $272K | Sell |
93,143
-7,664
| -8% | -$22.4K | ﹤0.01% | 2694 |
|
|
2020
Q4 | $236K | Buy |
100,807
+72,696
| +259% | +$170K | ﹤0.01% | 2513 |
|
|
2020
Q3 | $89K | Sell |
28,111
-75,857
| -73% | -$240K | ﹤0.01% | 2490 |
|
|
2020
Q2 | $375K | Buy |
+103,968
| New | +$375K | ﹤0.01% | 2267 |
|
|
2019
Q4 | – | Sell |
-16,295
| Closed | -$126K | – | 2760 |
|
|
2019
Q3 | $126K | Sell |
16,295
-63,830
| -80% | -$494K | ﹤0.01% | 2441 |
|
|
2019
Q2 | $452K | Sell |
80,125
-29,274
| -27% | -$165K | ﹤0.01% | 2166 |
|
|
2019
Q1 | $860K | Buy |
109,399
+18,209
| +20% | +$143K | ﹤0.01% | 1909 |
|
|
2018
Q4 | $614K | Buy |
91,190
+34,258
| +60% | +$231K | ﹤0.01% | 2038 |
|
|
2018
Q3 | $714K | Buy |
+56,932
| New | +$714K | ﹤0.01% | 1950 |
|
|
2017
Q3 | – | Sell |
-44,931
| Closed | -$398K | – | 2564 |
|
|
2017
Q2 | $398K | Buy |
44,931
+18,792
| +72% | +$166K | ﹤0.01% | 2048 |
|
|
2017
Q1 | $212K | Buy |
+26,139
| New | +$212K | ﹤0.01% | 2264 |
|
|
2016
Q3 | – | Sell |
-48,790
| Closed | -$498K | – | 2594 |
|
|
2016
Q2 | $498K | Buy |
+48,790
| New | +$498K | ﹤0.01% | 2066 |
|